VX11-770-109 Roll-Over Study Paediatric CF CFTR gating mutation

• Research type

  Research Study

• Full title

  A Phase 3, 2-Arm, Roll-Over Study to Evaluate the Long-term Safety and Pharmacodynamics of Ivacaftor Treatment in Pediatric Subjects With Cystic Fibrosis and a CFTR Gating Mutation

• IRAS ID

  131110

• Contact name

  Jane Davies

• Contact email

  j.c.davies@imperial.ac.uk

• Sponsor organisation

  Vertex Pharmaceuticals Incorporated

• Eudract number

  2012-000386-20

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  13/EM/0268

• Date of REC Opinion

  31 Jul 2013

• REC opinion

  Favourable Opinion